These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35357370)

  • 1. Transdermal estrogen therapy in menopausal women at increased risk for thrombotic events: a scoping review.
    Sobel TH; Shen W
    Menopause; 2022 Jan; 29(4):483-490. PubMed ID: 35357370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Menopause and risk of thromboembolic events. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
    Hugon-Rodin J; Perol S; Plu-Bureau G
    Gynecol Obstet Fertil Senol; 2021 May; 49(5):455-461. PubMed ID: 33757918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management.
    Trémollieres FA; André G; Letombe B; Barthélemy L; Pichard A; Gelas B; Lopès P
    Maturitas; 2022 Dec; 166():58-64. PubMed ID: 36058119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
    Canonico M; Oger E; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    J Thromb Haemost; 2006 Jun; 4(6):1259-65. PubMed ID: 16706969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
    Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
    Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
    Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative venous thromboembolic safety of oral and transdermal postmenopausal hormone therapies among women Veterans.
    Blondon M; Timmons AK; Baraff AJ; Floyd JS; Harrington LB; Korpak AM; Smith NL
    Menopause; 2021 Jul; 28(10):1125-1129. PubMed ID: 34313612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M
    Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
    Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
    Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis.
    Scarabin PY
    Climacteric; 2018 Aug; 21(4):341-345. PubMed ID: 29570359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
    Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
    Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should transdermal rather than oral estrogens be used in menopausal hormone therapy? A review.
    Fournier A
    Menopause Int; 2010 Mar; 16(1):23-32. PubMed ID: 20424283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What the Women's Health Initiative has taught us about menopausal hormone therapy.
    Chester RC; Kling JM; Manson JE
    Clin Cardiol; 2018 Feb; 41(2):247-252. PubMed ID: 29493798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary embolism in menopausal hormone therapy: a population-based register study.
    Sundell M; Spetz Holm AC; Fredrikson M; Hammar M; Hoffmann M; Brynhildsen J
    Climacteric; 2022 Dec; 25(6):615-621. PubMed ID: 36218141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea-based retrospective cohort study.
    Yuk JS; Kim JM
    Menopause; 2023 May; 30(5):497-505. PubMed ID: 36917757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.
    Khalil RA
    Biochem Pharmacol; 2013 Dec; 86(12):1627-42. PubMed ID: 24099797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy and venous thromboembolism.
    Bińkowska M
    Prz Menopauzalny; 2014 Oct; 13(5):267-72. PubMed ID: 26327865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.
    Cobin RH; Goodman NF;
    Endocr Pract; 2017 Jul; 23(7):869-880. PubMed ID: 28703650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.